Refractory cytopenia of childhood (Q39439): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
O subtipo mais comum de síndromes mielodisplásicas que afetam crianças. É caracterizada por citopenia persistente com menos de 5% de blastos na medula óssea e menos de 2% de blastos no sangue periférico.
description / endescription / en
 
The most common subtype of the myelodysplastic syndromes affecting children. It is characterised by persistent cytopenia with less than 5% blasts in the bone marrow and less than 2% blasts in the peripheral blood.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/699075426 / rank
 
Normal rank
Property / CURIE
 
CID11:2A38
Property / CURIE: CID11:2A38 / rank
 
Normal rank
Property / Canary Token
 
dki-india-2A38
Property / Canary Token: dki-india-2A38 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: D46.9 / rank
 
Normal rank

Latest revision as of 04:51, 13 August 2026

The most common subtype of the myelodysplastic syndromes affecting children. It is characterised by persistent cytopenia with less than 5% blasts in the bone marrow and less than 2% blasts in the peripheral blood.
Language Label Description Also known as
default for all languages
2A38
    English
    Refractory cytopenia of childhood
    The most common subtype of the myelodysplastic syndromes affecting children. It is characterised by persistent cytopenia with less than 5% blasts in the bone marrow and less than 2% blasts in the peripheral blood.

      Statements

      CID11:2A38
      0 references
      dki-india-2A38
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references